An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Journal article |
Vydáno: |
2013
|
Shrnutí: |
---|